Relative value of different outcomesThe GDG considered that the aim of this guideline was to improve rates of consent for organ donation through optimising all stages of the process. This would include maximising the number of potential donors by exploring an individual’s wish to donate.
A recommendation was therefore made on the inclusion of organ donation as a standard part of end-of-life planning.
Trade-off between benefits and harmsAllowing a patient to discuss their beliefs or values about organ donation is part of best practice at the end of life and should be part of all planned care (as specified by the GMC). Evidence also shows that if the family is aware of the patient’s wishes to donate, they are more likely to consent to organ donation.
Economic considerationsNone.
Quality of evidenceThere was a lack of high-quality evidence identified evaluating how the patient’s views on organ donation influence the family’s consent rate.
However, the evidence reviewed showed consistently that where patients’ views on donation were known, families were more likely to make a decision conforming with that view.
Other considerationsThe GDG highlighted the responsibility of the physician providing care under the GMC guidance ‘Treatment and care towards the end of life: good practice in decision making’12.

From: 2, Evidence review and recommendations

Cover of Organ Donation for Transplantation
Organ Donation for Transplantation: Improving Donor Identification and Consent Rates for Deceased Organ Donation.
NICE Clinical Guidelines, No. 135.
Centre for Clinical Practice at NICE (UK).
Copyright © 2011, National Institute for Health and Clinical Excellence.

All rights reserved. This material may be freely reproduced for educational and not-for-profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the express written permission of NICE.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.